GYRE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for organ fibrosis and inflammation.
GYRE | US
Overview
Corporate Details
- ISIN(s):
- US4037831033 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 12770 HIGH BLUFF DRIVE, 92130 SAN DIEGO
- Website:
- https://www.gyretx.com/
- Sector:
- Manufacturing
Description
Gyre Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for organ fibrosis and inflammatory diseases. The company develops small-molecule, anti-inflammatory, and anti-fibrotic drugs. Its lead drug candidate is Hydronidone (F351), which is being evaluated for the treatment of liver fibrosis, including cases associated with Chronic Hepatitis B (CHB) and Metabolic Dysfunction-Associated Steatohepatitis (MASH). The company's pipeline also includes other therapeutic candidates, such as Pirfenidone for pneumoconiosis, aimed at addressing unmet medical needs in chronic organ diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 21:32 | English | 7.0 KB | |||
| 2025-11-07 17:16 |
10-Q
|
English | 2.2 MB | ||
| 2025-11-06 22:55 |
8-K
|
English | 202.0 KB | ||
| 2025-09-10 11:00 |
8-K
|
English | 5.6 MB | ||
| 2025-08-26 18:09 |
FORM 4
|
English | 7.0 KB | ||
| 2025-08-26 18:03 |
FORM 3
|
English | 10.8 KB | ||
| 2025-08-22 09:05 |
8-K
|
English | 92.0 KB | ||
| 2025-08-11 19:07 |
10-Q
|
English | 2.1 MB | ||
| 2025-08-11 18:00 |
8-K
|
English | 207.3 KB | ||
| 2025-08-07 22:00 |
FORM 4
|
English | 7.0 KB | ||
| 2025-06-06 18:22 |
FORM 4
|
English | 7.0 KB | ||
| 2025-06-06 18:22 |
FORM 4
|
English | 7.1 KB | ||
| 2025-06-06 18:22 |
FORM 4
|
English | 7.0 KB | ||
| 2025-06-06 18:22 |
FORM 4
|
English | 7.0 KB | ||
| 2025-06-06 18:22 |
FORM 4
|
English | 7.0 KB |
Automate Your Workflow. Get a real-time feed of all GYRE THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GYRE THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GYRE THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
